Supporting exceptional science and technology
Malin invests in and supports highly innovative life sciences companies developing exceptional science and technology to deliver transformative outcomes for patients and create significant value for shareholders.
Our purpose is to create shareholder value through the application of long-term capital and strategic support to our investee companies to enable them to reach their value potential.
Malin is headquartered in Ireland and listed on the Euronext Growth Market of Euronext Dublin.
To deliver significant returns for our shareholders and transformative outcomes for patients by investing in and supporting highly innovative life sciences companies
Access to companies with compelling
value propositions spanning innovations
across multiple areas of healthcare
Delivery of transformative
outcomes for patients
Our Core Values
Science and innovation
We have deployed capital to support and actively work with companies developing ground-breaking innovative technology platforms in pursuit of cures for cancer and autoimmune and other diseases where current therapies are suboptimal or do not exist.
We work closely with talented individuals across our investee companies who share our goal of creating transformative new therapies for patients, particularly those with life threatening illnesses.
We operate the business with integrity and veracity with the best interests of our key stakeholders in mind. We seek to make a capital return for our investors while helping in the development of new therapies for patients.